Aura Biosciences Inc Statistics
Want to see AURA full AI Analyst Report?
Aura Biosciences Inc (AURA) Stock Statistics & Valuation Metrics
Total Valuation
Aura Biosciences Inc has a market cap or net worth of $739.97M. The enterprise value is $416.47M.
- Market Cap
- $739.97M
- Enterprise Value
- $416.47M
Share Statistics
Aura Biosciences Inc has 104,074,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 104,074,300
- Owned by Insiders
- 3.71%
- Owned by Institutions
- 32.07%
Financial Efficiency
Aura Biosciences Inc’s return on equity (ROE) is -0.78 and return on invested capital (ROIC) is -73.10%.
- Return on Equity (ROE)
- -0.78
- Return on Assets (ROA)
- -0.63
- Return on Invested Capital (ROIC)
- -73.10%
- Return on Capital Employed (ROCE)
- -0.75
- Revenue Per Employee
- 0
- Profits Per Employee
- -939.74K
- Employee Count
- 113
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Aura Biosciences Inc is -4.26. Aura Biosciences Inc’s PEG ratio is -0.28.
- PE Ratio
- -4.26
- PS Ratio
- 0.00
- PB Ratio
- 2.75
- Price to FCF
- -6.75
- Price to Operating Cash Flow
- -7.23
- PEG Ratio
- -0.28
Income Statement
In the last 12 months, Aura Biosciences Inc had revenue of 0 and earned -106.19M in profits. Earnings per share was -1.76.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -112.79M
- Pretax Income
- -106.08M
- Net Income
- -106.19M
- EBITDA
- -104.95M
- Earnings Per Share (EPS)
- -1.76
Cash Flow
In the last 12 months, operating cash flow was -109.30M and capital expenditures -379,000, giving a free cash flow of -109.68M billion.
- Operating Cash Flow
- -109.30M
- Free Cash Flow
- -109.68M
- Free Cash Flow per Share
- -0.99
Dividends & Yields
Aura Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -14.59%
- Earnings Yield
- -17.07%
Stock Price Statistics
- Beta
- 1.52
- 52-Week Price Change
- 28.57%
- 50-Day Moving Average
- 6.54
- 200-Day Moving Average
- 6.81
- Relative Strength Index (RSI)
- 57.29
- Average Volume (3m)
- 900.47K
Important Dates
Aura Biosciences Inc upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Mar 30, 2027
- Ex-Dividend Date
- ―
Financial Position
Aura Biosciences Inc as a current ratio of 8.15, with Debt / Equity ratio of 12.69%
- Current Ratio
- 8.15
- Quick Ratio
- 8.15
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.40
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Aura Biosciences Inc has paid 108.00K in taxes.
- Income Tax
- 108.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Aura Biosciences Inc EV to EBITDA ratio is -5.14, with an EV/FCF ratio of -6.62.
- EV to Sales
- 0.00
- EV to EBITDA
- -5.14
- EV to Free Cash Flow
- -6.62
- EV to Operating Cash Flow
- -6.65
Balance Sheet
Aura Biosciences Inc has $297.23M in cash and marketable securities with $16.17M in debt, giving a net cash position of $281.06M billion.
- Cash & Marketable Securities
- $297.23M
- Total Debt
- $16.17M
- Net Cash
- $281.06M
- Net Cash Per Share
- $2.70
- Tangible Book Value Per Share
- $2.59
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Aura Biosciences Inc is $18.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $18.00
- Price Target Upside
- 153.16% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 13.33%
Scores
- Smart Score
- 6
- AI Score
- 52

